GRANT THORNTON LIMITED

Company number 02917818 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: GRANT THORNTON LIMITED

1. Financial Health Score: A- (Structural & Compliance Health) Explanation: Based on the available corporate vitals, the company exhibits excellent administrative health with no symptoms of compliance distress. However, the score is held back slightly due to the extremely thin capitalization (£1 share capital) and a highly complex corporate anatomy (multiple PSCs with overlapping control), which is typical of holding companies but requires careful monitoring. Please note that a full financial health score requires the "blood test" results (filed profit & loss and balance sheet figures), which are not present in this specific diagnostic chart.

2. Key Vital Signs * Compliance Pulse (Filing Status): Strong and steady. The company’s accounts are up to date (made up to 31 Dec 2024) and not overdue. The confirmation statement is also current. This indicates a healthy administrative heartbeat with no signs of regulatory distress. * Corporate Anatomy (PSC Structure): Complex. The patient has multiple Persons with Significant Control (PSCs)—including Pacioli UK Midco Limited and various Grant Thornton entities—each holding more than 75% of shares and voting rights. This overlapping control structure is a common symptom of a holding company sitting within a larger corporate group or private equity structure. * Capital Reserves (Share Capital): Nominal. The share capital is exactly £1.00. While this might look like a symptom of anemia, for a holding company (SIC code 64209), this is often perfectly normal, acting merely as a structural vessel rather than a trading engine. * Corporate Age: Incorporated in 1994, this is a mature entity with a long clinical history, having changed its name from Barfreston Limited shortly after birth.

3. Diagnosis The patient is a mature, structurally sound holding vehicle operating within the wider Grant Thornton corporate anatomy. The primary diagnosis is that of a "Corporate Holding Vessel"—an entity designed for structural, legal, or financial engineering rather than direct trading with the public. The £1 share capital and the SIC code (Activities of other holding companies) confirm this.

The overlapping >75% ownership by multiple corporate PSCs indicates a complex group restructuring or a joint-venture structure, likely tied to private equity investment (suggested by the presence of "Pacioli UK Midco Limited," as "Midco" typically denotes a "middle" company in a leveraged buyout structure). While the administrative vitals are perfectly healthy, the complex ownership means that the financial wellness of this specific entity is entirely dependent on the health of the parent group.

4. Recommendations * Monitor the Parent Group's Vitals: Because this entity is a holding vessel with nominal capital, its true financial wellness can only be assessed by examining the consolidated group financial statements. Request and review the "blood work" of the ultimate parent company to check for symptoms of distress. * Maintain Administrative Hygiene: Continue the excellent compliance posture. As a complex holding structure, any administrative delays (overdue filings) could trigger regulatory symptoms or breach group covenants. * Inter-company Loan Health Check: Given the £1 share capital, it is highly likely this company operates via inter-company loans or share premium accounts. Ensure that any inter-company balances are properly documented and that the entity maintains sufficient distributable reserves if it is expected to pay dividends up the corporate chain.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 31 July 2026